Core Alternative Capital Avanos Medical, Inc. Transaction History
Core Alternative Capital
- $359 Million
- Q2 2025
A detailed history of Core Alternative Capital transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Core Alternative Capital holds 30 shares of AVNS stock, worth $324. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30Holding current value
$324% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVNS
# of Institutions
306Shares Held
43.6MCall Options Held
3.5KPut Options Held
13.2K-
Black Rock Inc. New York, NY7.01MShares$75.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$57.9 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.76MShares$40.7 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.6MShares$28.1 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2MShares$21.6 Million0.44% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $503M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...